Cancer

Cancer Research in Space for Life on Earth: Five Projects Selected Through ISS National Lab Solicitation in Partnership With NASA

Inaugural Igniting Innovation research announcement is providing more than $7 million in funding to advance cancer research through space-based R&D…

2 years ago

New Funding Announced for Revolutionary Disease Detection Technology

Noze is the first-ever Canadian company to receive investment funding from the Bill & Melinda Gates Foundation.  MONTREAL, July 30,…

2 years ago

Slope Appoints Jim Munz as Chief Product & Technology Officer

Former Veeva and ERT clinical trial technology executive will drive strategy towards a complete, tech-enabled biospecimen lifecycle solution RICHMOND, Va.,…

2 years ago

Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities

BURLINGTON, N.C., and FREMONT, Calif., July 29, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive…

2 years ago

Prostate Cancer Foundation Canada Announces Leadership Transition

Dr. Abby C. Collier will take over from Leah Lariviere as Executive Director, effective August 1, 2024Vancouver, British Columbia--(Newsfile Corp.…

2 years ago

Verana Health and HealthVerity Partner to Advance Use of Real-World Evidence in Research

Data partnership initiative expands access to critical healthcare data in ophthalmology, urology and neurologySAN FRANCISCO, July 30, 2024 (GLOBE NEWSWIRE)…

2 years ago

Georgiamune Announces First Patient Dosed in A First-In-Class Phase 1 Cancer Treatment Trial of GIM-531

GAITHERSBURG, Md., July 30, 2024 (GLOBE NEWSWIRE) -- Today, Georgiamune Inc., a privately held, clinical-stage biotechnology company, announced that the first…

2 years ago

Nascent Biotech Presents at the July Emerging Growth Conference

Nascent CEO-Sean Carrick-Discusses Phase I Results and Forward Clinical Strategy while laying out Investment Opportunity of the Company  NORTH PALM…

2 years ago

CNS Pharmaceuticals Expands Pipeline with In-License of Late Stage, Novel Potential Blood Brain Barrier Permeable Abeotaxane for Treatment of Brain Malignancies

Strategic in-license from Cortice Bioscience is highly synergistic with the ongoing potentially pivotal Berubicin program and demonstrates further commitment to…

2 years ago